<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Certain Plant-Derived Recombinant Human Serum Albumins (“rHSA”) and Products Containing Same; Notice of the Commission's Final Determination Finding a Violation of Section 337; Issuance of a Limited Exclusion Order and Cease and Desist Orders; Termination of the Investigation</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Certain Plant-Derived Recombinant Human Serum Albumins (“rHSA”) and Products Containing Same; Notice of the Commission's Final Determination Finding a Violation of Section 337; Issuance of a Limited Exclusion Order and Cease and Desist Orders; Termination of the Investigation</h1>
    <p class="timestamp">Published: 2022-09-16 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>Notice is hereby given that the U.S. International Trade Commission has found a violation of section 337 in the above-captioned investigation. The Commission has determined to issue: (1) a limited exclusion order ("LEO") prohibiting the unlicensed entry of infringing plant-derived recombinant human serum albumins ("rHSA") and products containing the same covered by certain claims of U.S. Patent No. 10,618,951 that are manufactured by or on behalf of, or imported by or on behalf of, respondents W...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> International Trade Commission</p>
    <p><strong>Document Number:</strong> 2022-20042</p>
    <p><strong>Publication Date:</strong> 2022-09-16</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/09/16/2022-20042/certain-plant-derived-recombinant-human-serum-albumins-rhsa-and-products-containing-same-notice-of">https://www.federalregister.gov/documents/2022/09/16/2022-20042/certain-plant-derived-recombinant-human-serum-albumins-rhsa-and-products-containing-same-notice-of</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-20042</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
